Practice Management

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells

I would be interested as well.  I would also be interested in collaborating on a policy.

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells

I would be interested as well.  I would also be interested in collaborating on a policy.

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells

I would be interested as well.  I would also be interested in collaborating on a policy.

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells

We have an IDTF that we are considering this for.  It will be helpful, even if it only extends through the end of the year.  

The IDTF owner thinks that there needs to be a physician extender present when the physician is supervising remotely.  I don't think that's the case.  As I understand it, there are 2 additional ways to achieve Direct Supervision other than through a radiologist on site. The first is to have an NP or other form of approved physician extender on site supervising the study. The other way is to have the physician supervise the study via virtual presence rather than physical presence. Virtual presence, to my understanding, does not require a physician extender on site.  

Please advise.  Thank you.

I would be interested as well.  I would also be interested in collaborating on a policy.

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells

I heard a rumor last week that Medicare is extending the virtual supervision for an additional 2 years.  I am trying to confirm.  I have not seen anything in writing.

We have an IDTF that we are considering this for.  It will be helpful, even if it only extends through the end of the year.  

The IDTF owner thinks that there needs to be a physician extender present when the physician is supervising remotely.  I don't think that's the case.  As I understand it, there are 2 additional ways to achieve Direct Supervision other than through a radiologist on site. The first is to have an NP or other form of approved physician extender on site supervising the study. The other way is to have the physician supervise the study via virtual presence rather than physical presence. Virtual presence, to my understanding, does not require a physician extender on site.  

Please advise.  Thank you.

I would be interested as well.  I would also be interested in collaborating on a policy.

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells

I heard a rumor last week that Medicare is extending the virtual supervision for an additional 2 years.  I am trying to confirm.  I have not seen anything in writing.

We have an IDTF that we are considering this for.  It will be helpful, even if it only extends through the end of the year.  

The IDTF owner thinks that there needs to be a physician extender present when the physician is supervising remotely.  I don't think that's the case.  As I understand it, there are 2 additional ways to achieve Direct Supervision other than through a radiologist on site. The first is to have an NP or other form of approved physician extender on site supervising the study. The other way is to have the physician supervise the study via virtual presence rather than physical presence. Virtual presence, to my understanding, does not require a physician extender on site.  

Please advise.  Thank you.

I would be interested as well.  I would also be interested in collaborating on a policy.

RBMA Forum,

If you have successfully implemented a remote contrast supervision policy in the past year please advise if you are willing to discuss.

Thank you in advance for your consideration of this request.

Best,

Richard Sorrells